Efficacy and Safety of UI05MSP015CT in Functional Dyspepsia

Summary

This study is a multi-center, randomized, active-controlled, double-blind, non-inferiority, phase III clinical trial evaluating efficacy and safety of once-daily mosapride (UI05MSP015CT) in patients with functional dyspepsia.

Timeline

Start

2014-11-05

Primary completion

2015-09-05

Completion

2015-10-12

Drugs

Indications